{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:45:05Z","timestamp":1790729105318,"version":"4.1.0"},"reference-count":377,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2020.00315","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T17:28:28Z","timestamp":1588008508000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":122,"title":["Endocannabinoid System Components as Potential Biomarkers in Psychiatry"],"prefix":"10.3389","volume":"11","author":[{"given":"Francisco","family":"Navarrete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Salud","family":"Garc\u00eda-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Jurado-Barba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ani","family":"Gasparyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaya","family":"Austrich-Olivares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Manzanares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(15)00505-2","article-title":"Estimating the true global burden of mental illness","volume":"3","author":"Vigo","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.02.042","article-title":"Psychiatric disorders: diagnosis to therapy","volume":"157","author":"Krystal","year":"2014","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv042","article-title":"Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank","volume":"18","author":"Scarr","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000443549","article-title":"Biomarkers in Psychiatry - A Critique","volume":"23","author":"Venkatasubramanian","year":"2016","journal-title":"Ann Neurosci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam","year":"2013","journal-title":"Annu Rev Psychol"},{"key":"B7","volume-title":"The endocannabinoid system and human brain functions: insight from memory, motor, and mood pathologies, The endocananbinoid system: genetics, biochemistry, brain disorders, and therapy.","author":"Ashton","year":"2017"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/BF03033223","article-title":"Role of endocannabinoid system in mental diseases","volume":"6","author":"Manzanares","year":"2004","journal-title":"Neurotox Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2011.00063","article-title":"Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects","volume":"5","author":"Marco","year":"2011","journal-title":"Front Behav Neurosci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.expneurol.2010.03.018","article-title":"The endocannabinoid system and psychiatric disorders","volume":"224","author":"Parolaro","year":"2010","journal-title":"Exp Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/JCP.0000000000000581","article-title":"Targeting the Endocannabinoid System in Psychiatric Illness","volume":"36","author":"Katzman","year":"2016","journal-title":"J Clin Psychopharmacol"},{"key":"B12","unstructured":"Published online at OurWorldInData.org\n            RitchieH\n            RoserM\n          2020"},{"key":"B13","doi-asserted-by":"crossref","DOI":"10.1017\/9781107445130","volume-title":"The Global Epidemiology of Trauma Exposure and Posttraumatic Stress Disorder.","author":"Bromet","year":"2018"},{"key":"B14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12402-016-0208-3","article-title":"The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys","volume":"9","author":"Fayyad","year":"2017","journal-title":"Atten Defic Hyperact Disord"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-neuro-062111-150420","article-title":"Multiple functions of endocannabinoid signaling in the brain","volume":"35","author":"Katona","year":"2012","journal-title":"Annu Rev Neurosci"},{"key":"B16","first-page":"37","volume-title":"Cannabinoids and the brain: the effects of endogenous and exogenous cannabinoids on brain systems and function, The complex connection between cannabis and schizophrenia.","author":"Atkinson","year":"2018"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System","volume":"19","author":"Zou","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/3-540-26573-2_10","article-title":"Distribution of cannabinoid receptors in the central and peripheral nervous system","volume":"168","author":"Mackie","year":"2005","journal-title":"Handb Exp Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/alcalc\/agh110","article-title":"The endocannabinoid system: physiology and pharmacology","volume":"40","author":"Rodriguez de Fonseca","year":"2005","journal-title":"Alcohol Alcohol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/s0306-4522(97)00436-3","article-title":"Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system","volume":"83","author":"Tsou","year":"1998","journal-title":"Neuroscience"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/cne.24066","article-title":"Anatomical characterization of the cannabinoid CB1 receptor in cell-type-specific mutant mouse rescue models","volume":"525","author":"Gutierrez-Rodriguez","year":"2017","journal-title":"J Comp Neurol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2017.02.002","article-title":"The CB1 Receptor as the Cornerstone of Exostasis","volume":"93","author":"Piazza","year":"2017","journal-title":"Neuron"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/npp.2017.206","article-title":"CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity","volume":"43","author":"Busquets-Garcia","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(90)90124-S","article-title":"The cannabinoid receptor: biochemical, anatomical and behavioral characterization","volume":"13","author":"Howlett","year":"1990","journal-title":"Trends Neurosci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-3-319-20825-1_3","article-title":"Distribution of the Endocannabinoid System in the Central Nervous System","volume":"231","author":"Hu","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/89953","article-title":"Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis","volume":"7","author":"Batkai","year":"2001","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/37371","article-title":"Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock","volume":"390","author":"Wagner","year":"1997","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(97)82001-3","article-title":"Pharmacology of cannabinoid CB1 and CB2 receptors","volume":"74","author":"Pertwee","year":"1997","journal-title":"Pharmacol Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1054\/plef.2001.0341","article-title":"Cannabinoid receptors and their ligands","volume":"66","author":"Pertwee","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B32","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","article-title":"Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations","volume":"232","author":"Galiegue","year":"1995","journal-title":"Eur J Biochem"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2174\/187152709789824660","article-title":"The endocannabinoid system and pain","volume":"8","author":"Guindon","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1017\/S1462399409000957","article-title":"Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation","volume":"11","author":"Cabral","year":"2009","journal-title":"Expert Rev Mol Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","article-title":"Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains","volume":"23","author":"Benito","year":"2003","journal-title":"J Neurosci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2377-6-12","article-title":"COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells\/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord","volume":"6","author":"Yiangou","year":"2006","journal-title":"BMC Neurol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s001090000177","article-title":"Control of the cell survival\/death decision by cannabinoids","volume":"78","author":"Guzman","year":"2001","journal-title":"J Mol Med (Berl)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1126\/science.1115740","article-title":"Identification and functional characterization of brainstem cannabinoid CB2 receptors","volume":"310","author":"Van Sickle","year":"2005","journal-title":"Science"},{"key":"B40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","article-title":"Cannabinoid CB2 receptors: immunohistochemical localization in rat brain","volume":"1071","author":"Gong","year":"2006","journal-title":"Brain Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1159\/000100778","article-title":"Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain","volume":"54","author":"Onaivi","year":"2006","journal-title":"Neuropsychobiology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1369.052","article-title":"Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain","volume":"1074","author":"Onaivi","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00819.x","article-title":"Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors","volume":"160","author":"Garcia-Gutierrez","year":"2010","journal-title":"Br J Pharmacol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1413210111","article-title":"Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707584","article-title":"CB2 receptors in the brain: role in central immune function","volume":"153","author":"Cabral","year":"2008","journal-title":"Br J Pharmacol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/s13311-018-0610-y","article-title":"Alterations in Gene and Protein Expression of Cannabinoid CB2 and GPR55 Receptors in the Dorsolateral Prefrontal Cortex of Suicide Victims","volume":"15","author":"Garcia-Gutierrez","year":"2018","journal-title":"Neurotherapeutics"},{"key":"B47","doi-asserted-by":"publisher","first-page":"17410","DOI":"10.1038\/s41598-017-17796-y","article-title":"Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"B48","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"Cannabinoid receptors and their ligands: beyond CB(1) and CB(2)","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol Rev"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol Rev"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2011.03.003","article-title":"Supply and demand for endocannabinoids","volume":"34","author":"Alger","year":"2011","journal-title":"Trends Neurosci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"B52","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M306642200","article-title":"Molecular characterization of a phospholipase D generating anandamide and its congeners","volume":"279","author":"Okamoto","year":"2004","journal-title":"J Biol Chem"},{"key":"B54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrn3876","article-title":"Endocannabinoid signalling and the deteriorating brain","volume":"16","author":"Di Marzo","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-6980(02)00053-9","article-title":"Endocannabinoid hydrolases","author":"Ueda","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(03)00145-3","article-title":"Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling","volume":"119","author":"Egertova","year":"2003","journal-title":"Neuroscience"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/molecules191117078","article-title":"Endocannabinoids, related compounds and their metabolic routes","volume":"19","author":"Fezza","year":"2014","journal-title":"Molecules"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5693-09.2010","article-title":"Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice","volume":"30","author":"Gao","year":"2010","journal-title":"J Neurosci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2010.01.021","article-title":"The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission","volume":"65","author":"Tanimura","year":"2010","journal-title":"Neuron"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B61","first-page":"27","article-title":"Neuromodulatory functions of the endocannabinoid system","volume":"29","author":"Marsicano","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"B62","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.bcp.2018.07.009","article-title":"The endocannabinoid system in mental disorders: Evidence from human brain studies","volume":"157","author":"Ibarra-Lecue","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"B63","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM)","year":"2013"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0000000000000068","article-title":"Consequences of early life stress on the expression of endocannabinoid-related genes in the rat brain","volume":"25","author":"Marco","year":"2014","journal-title":"Behav Pharmacol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2018.01.045","article-title":"Impaired glucocorticoid-mediated HPA axis negative feedback induced by juvenile social isolation in male rats","volume":"133","author":"Boero","year":"2018","journal-title":"Neuropharmacology"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-007-0927-4","article-title":"Cat odour-induced anxiety\u2013a study of the involvement of the endocannabinoid system","volume":"198","author":"Sutt","year":"2008","journal-title":"Psychopharmacol (Berl)"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2012.11.018","article-title":"Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test","volume":"240","author":"Cagni","year":"2013","journal-title":"Behav Brain Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/npp.2015.166","article-title":"Neurobiological Interactions Between Stress and the Endocannabinoid System","volume":"41","author":"Morena","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/nrn4036","article-title":"The endocannabinoid system in guarding against fear, anxiety and stress","volume":"16","author":"Lutz","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2002.02192.x","article-title":"The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety","volume":"16","author":"Haller","year":"2002","journal-title":"Eur J Neurosci"},{"key":"B71","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/01.fbp.0000135704.56422.40","article-title":"CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents","volume":"15","author":"Haller","year":"2004","journal-title":"Behav Pharmacol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2004.03293.x","article-title":"Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice","volume":"19","author":"Haller","year":"2004","journal-title":"Eur J Neurosci"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-200509000-00005","article-title":"A role for cannabinoid CB1 receptors in mood and anxiety disorders","volume":"16","author":"Witkin","year":"2005","journal-title":"Behav Pharmacol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.2174\/138161205774370780","article-title":"Participation of the cannabinoid system in the regulation of emotional-like behaviour","volume":"11","author":"Valverde","year":"2005","journal-title":"Curr Pharm Des"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109106910","article-title":"The cannabinoid CB1 receptor is involved in the anxiolytic, sedative and amnesic actions of benzodiazepines","volume":"24","author":"Garcia-Gutierrez","year":"2010","journal-title":"J Psychopharmacol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neulet.2019.03.010","article-title":"Cannabinoid CB1 receptors mediate the anxiolytic effects induced by systemic alprazolam and intra-periaqueductal gray 5-HT1A receptor activation","volume":"703","author":"Batista","year":"2019","journal-title":"Neurosci Lett"},{"key":"B77","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.pbb.2007.11.001","article-title":"Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice","volume":"89","author":"Naderi","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2005.01.029","article-title":"Endocannabinoid system and stress and anxiety responses","volume":"81","author":"Viveros","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"B79","article-title":"Study the Effect of Endocannabinoid System on Rat Behavior in Elevated Plus-Maze","volume":"6","author":"Komaki","year":"2015","journal-title":"Basic Clin Neurosci"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-018-0064-2","article-title":"Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2","volume":"43","author":"Lisboa","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(01)00578-0","article-title":"Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters","volume":"70","author":"Arevalo","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199701200-00023","article-title":"Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat","volume":"8","author":"Navarro","year":"1997","journal-title":"Neuroreport"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2004.03556.x","article-title":"Genetic deletion and pharmacological blockade of CB1 receptors modulates anxiety in the shock-probe burying test","volume":"20","author":"Degroot","year":"2004","journal-title":"Eur J Neurosci"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2003.12.019","article-title":"Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test","volume":"77","author":"Genn","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2004.06.069","article-title":"Enhancement of anxiety-like responsiveness to the cannabinoid CB(1) receptor agonist HU-210 following chronic stress","volume":"499","author":"Hill","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-200509000-00013","article-title":"Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naive and plus-maze-experienced mice","volume":"16","author":"Rodgers","year":"2005","journal-title":"Behav Pharmacol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2009.11.002","article-title":"Potential anxiogenic effects of cannabinoid CB1 receptor antagonists\/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142","volume":"20","author":"Sink","year":"2010","journal-title":"Eur Neuropsychopharmacol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.123","article-title":"Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission","volume":"37","author":"Rey","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.18869\/nirp.bcn.8.2.129","article-title":"Interaction Between the Cannabinoid and Vanilloid Systems on Anxiety in Male Rats","volume":"8","author":"Faraji","year":"2017","journal-title":"Basic Clin Neurosci"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2009.08.017","article-title":"Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids","volume":"33","author":"Campos","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2012.03.007","article-title":"The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior","volume":"63","author":"Fogaca","year":"2012","journal-title":"Neuropharmacology"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2015.07.019","article-title":"The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors","volume":"293","author":"Batista","year":"2015","journal-title":"Behav Brain Res"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/gbb.12045","article-title":"CB1 receptor signaling regulates social anxiety and memory","volume":"12","author":"Litvin","year":"2013","journal-title":"Genes Brain Behav"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-001-0946-5","article-title":"Involvement of CB1 cannabinoid receptors in emotional behaviour","volume":"159","author":"Martin","year":"2002","journal-title":"Psychopharmacol (Berl)"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2008.12.035","article-title":"Modulation of anxiety by acute blockade and genetic deletion of the CB(1) cannabinoid receptor in mice together with biogenic amine changes in the forebrain","volume":"200","author":"Thiemann","year":"2009","journal-title":"Behav Brain Res"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2002.01957.x","article-title":"Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour","volume":"15","author":"Maccarrone","year":"2002","journal-title":"Eur J Neurosci"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2015.12.005","article-title":"Sex-dependence of anxiety-like behavior in cannabinoid receptor 1 (Cnr1) knockout mice","volume":"300","author":"Bowers","year":"2016","journal-title":"Behav Brain Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijdevneu.2018.07.011","article-title":"Sex-specific effects of CB1 receptor antagonism and stress in adolescence on anxiety, corticosterone concentrations, and contextual fear in adulthood in rats","volume":"69","author":"Simone","year":"2018","journal-title":"Int J Dev Neurosci"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2004.01.003","article-title":"Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors","volume":"46","author":"Uriguen","year":"2004","journal-title":"Neuropharmacology"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109358204","article-title":"Decreased GABAA and GABAB receptor functional activity in cannabinoid CB1 receptor knockout mice","volume":"25","author":"Uriguen","year":"2011","journal-title":"J Psychopharmacol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2006.10.013","article-title":"Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray","volume":"52","author":"Moreira","year":"2007","journal-title":"Neuropharmacology"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114566259","article-title":"Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses","volume":"29","author":"Batista","year":"2015","journal-title":"J Psychopharmacol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-014-3793-x","article-title":"Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats","volume":"232","author":"Viana","year":"2015","journal-title":"Psychopharmacol (Berl)"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2008.07.032","article-title":"Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test","volume":"593","author":"Lisboa","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.01.022","article-title":"Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks","volume":"148","author":"Viana","year":"2019","journal-title":"Neuropharmacology"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2279-15.2016","article-title":"Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala","volume":"36","author":"Di","year":"2016","journal-title":"J Neurosci"},{"key":"B107","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neuropharm.2016.08.020","article-title":"Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety","volume":"111","author":"Morena","year":"2016","journal-title":"Neuropharmacology"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2018.04.018","article-title":"The Lateral Habenula Directs Coping Styles Under Conditions of Stress via Recruitment of the Endocannabinoid System","volume":"84","author":"Berger","year":"2018","journal-title":"Biol Psychiatry"},{"key":"B109","article-title":"Cannabinoid system of the lateral septum in the modulation of anxiety-like behaviors in rats","volume":"16","author":"Hajizadeh Moghaddam","year":"2013","journal-title":"Arch Iran Med"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301330","article-title":"Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats","volume":"32","author":"Rubino","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2007.06.024","article-title":"Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex","volume":"18","author":"Rubino","year":"2008","journal-title":"Cereb Cortex"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119827799","article-title":"Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats","volume":"33","author":"Hartmann","year":"2019","journal-title":"J Psychopharmacol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2014.05.017","article-title":"The microinjection of a cannabinoid agonist into the accumbens shell induces anxiogenesis in the elevated plus-maze","volume":"124","author":"Kochenborger","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"B114","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.pnpbp.2015.01.005","article-title":"Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: additional evidence","volume":"59","author":"Lisboa","year":"2015","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1007\/s00429-017-1411-5","article-title":"Addressing sufficiency of the CB1 receptor for endocannabinoid-mediated functions through conditional genetic rescue in forebrain GABAergic neurons","volume":"222","author":"Remmers","year":"2017","journal-title":"Brain Struct Funct"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2007.06.024","article-title":"CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour","volume":"54","author":"Rubino","year":"2008","journal-title":"Neuropharmacology"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2017.11.029","article-title":"Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to cannabinoid-induced effects","volume":"192","author":"Mendiguren","year":"2018","journal-title":"Life Sci"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2015.00235","article-title":"Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxiety-like behavior and sociability","volume":"9","author":"Haring","year":"2015","journal-title":"Front Behav Neurosci"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110376688","article-title":"Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems","volume":"25","author":"Zarrindast","year":"2011","journal-title":"J Psychopharmacol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0b013e3283123c83","article-title":"Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system","volume":"19","author":"Zarrindast","year":"2008","journal-title":"Behav Pharmacol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/bs.irn.2015.09.002","article-title":"Evidence for a Role of Adolescent Endocannabinoid Signaling in Regulating HPA Axis Stress Responsivity and Emotional Behavior Development","volume":"125","author":"Lee","year":"2015","journal-title":"Int Rev Neurobiol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2737-14.2015","article-title":"Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety","volume":"35","author":"Gray","year":"2015","journal-title":"J Neurosci"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2016.01.004","article-title":"Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function","volume":"66","author":"Gray","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.31024","article-title":"Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with 5-HTTLPR affect the anxious phenotype","author":"Lazary","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2019.104407","article-title":"Disruption of an enhancer associated with addictive behaviour within the cannabinoid receptor-1 gene suggests a possible role in alcohol intake, cannabinoid response and anxiety-related behaviour","volume":"109","author":"Hay","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158950","article-title":"Putative Epigenetic Involvement of the Endocannabinoid System in Anxiety- and Depression-Related Behaviors Caused by Nicotine as a Stressor","volume":"11","author":"Hayase","year":"2016","journal-title":"PloS One"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2016.10.008","article-title":"Chronic stress leads to epigenetic dysregulation in the neuropeptide-Y and cannabinoid CB1 receptor genes in the mouse cingulate cortex","volume":"113","author":"Lomazzo","year":"2017","journal-title":"Neuropharmacology"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2017.03.002","article-title":"Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety","volume":"82","author":"Bedse","year":"2017","journal-title":"Biol Psychiatry"},{"key":"B129","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41398-018-0141-7","article-title":"Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors","volume":"8","author":"Bedse","year":"2018","journal-title":"Transl Psychiatry"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1704065114","article-title":"Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake","volume":"114","author":"Chicca","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2010.12.002","article-title":"Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay","volume":"98","author":"Kinsey","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2011.04.022","article-title":"Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses","volume":"70","author":"Busquets-Garcia","year":"2011","journal-title":"Biol Psychiatry"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-018-0274-7","article-title":"Impaired anandamide\/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses","volume":"44","author":"Zimmermann","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2017.06.006","article-title":"The effects of enhancing endocannabinoid signaling and blocking corticotrophin releasing factor receptor in the amygdala and hippocampus on the consolidation of a stressful event","volume":"27","author":"Aisenberg","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301061","article-title":"Anxiolytic-like properties of the anandamide transport inhibitor AM404","volume":"31","author":"Bortolato","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2010.01.062","article-title":"Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience","volume":"167","author":"Campos","year":"2010","journal-title":"Neuroscience"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1503\/jpn.160116","article-title":"Fatty acid amide hydrolase inhibitors produce rapid anti-anxiety responses through amygdala long-term depression in male rodents","volume":"42","author":"Duan","year":"2017","journal-title":"J Psychiatry Neurosci"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.13174","article-title":"Phenolic compounds from nutmeg (Myristica fragrans Houtt.) inhibit the endocannabinoid-modulating enzyme fatty acid amide hydrolase","volume":"71","author":"El-Alfy","year":"2019","journal-title":"J Pharm Pharmacol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/s41598-018-20895-z","article-title":"The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents","volume":"8","author":"Griebel","year":"2018","journal-title":"Sci Rep"},{"key":"B140","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat Med"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137034","article-title":"Potential Therapeutic Value of a Novel FAAH Inhibitor for the Treatment of Anxiety","volume":"10","author":"Marco","year":"2015","journal-title":"PloS One"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2007.08.011","article-title":"The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition","volume":"54","author":"Scherma","year":"2008","journal-title":"Neuropharmacology"},{"key":"B143","doi-asserted-by":"publisher","first-page":"e408","DOI":"10.1038\/tp.2014.53","article-title":"Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation","volume":"4","author":"Bluett","year":"2014","journal-title":"Transl Psychiatry"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2012.90","article-title":"Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure","volume":"18","author":"Hill","year":"2013","journal-title":"Mol Psychiatry"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2251-18.2018","article-title":"Upregulation of Anandamide Hydrolysis in the Basolateral Complex of Amygdala Reduces Fear Memory Expression and Indices of Stress and Anxiety","volume":"39","author":"Morena","year":"2019","journal-title":"J Neurosci"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1124\/mol.110.064196","article-title":"Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition","volume":"78","author":"Rossi","year":"2010","journal-title":"Mol Pharmacol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2007.07.005","article-title":"Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors","volume":"54","author":"Moreira","year":"2008","journal-title":"Neuropharmacology"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1494-7","article-title":"Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats","volume":"204","author":"Haller","year":"2009","journal-title":"Psychopharmacol (Berl)"},{"key":"B149","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/npp.2008.98","article-title":"Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels","volume":"34","author":"Micale","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv091","article-title":"Impaired 2-AG Signaling in Hippocampal Glutamatergic Neurons: Aggravation of Anxiety-Like Behavior and Unaltered Seizure Susceptibility","volume":"19","author":"Guggenhuber","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2013.05.027","article-title":"Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray","volume":"252","author":"Almeida-Santos","year":"2013","journal-title":"Behav Brain Res"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1177\/0269881117704986","article-title":"2-Arachidonoylglycerol endocannabinoid signaling coupled to metabotropic glutamate receptor type-5 modulates anxiety-like behavior in the rat ventromedial prefrontal cortex","volume":"31","author":"Almeida-Santos","year":"2017","journal-title":"J Psychopharmacol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2011.04.010","article-title":"Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats","volume":"64","author":"Sciolino","year":"2011","journal-title":"Pharmacol Res"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2013.03.017","article-title":"Monoacylglycerol lipase inhibition-induced changes in plasma corticosterone levels, anxiety and locomotor activity in male CD1 mice","volume":"63","author":"Aliczki","year":"2013","journal-title":"Horm Behav"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.06.082","article-title":"Endocannabinoid-Mediated Plasticity in Nucleus Accumbens Controls Vulnerability to Anxiety after Social Defeat Stress","volume":"16","author":"Bosch-Bouju","year":"2016","journal-title":"Cell Rep"},{"key":"B156","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.euroneuro.2015.11.014","article-title":"Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey","volume":"26","author":"Gobira","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/jnc.13267","article-title":"Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB(1)R signaling and anxiety-like behavior","volume":"135","author":"Imperatore","year":"2015","journal-title":"J Neurochem"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.03.033","article-title":"Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid Levels","volume":"79","author":"Jenniches","year":"2016","journal-title":"Biol Psychiatry"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.11.001","article-title":"Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation","volume":"9","author":"Shonesy","year":"2014","journal-title":"Cell Rep"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110379507","article-title":"Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice","volume":"25","author":"Garcia-Gutierrez","year":"2011","journal-title":"J Psychopharmacol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2014.06.003","article-title":"beta-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice","volume":"135","author":"Bahi","year":"2014","journal-title":"Physiol Behav"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2017.03.061","article-title":"Anxious behavior induces elevated hippocampal Cb2 receptor gene expression","volume":"352","author":"Robertson","year":"2017","journal-title":"Neuroscience"},{"key":"B163","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuroscience.2017.08.053","article-title":"Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse hippocampus","volume":"363","author":"Li","year":"2017","journal-title":"Neuroscience"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1981.tb02617.x","article-title":"The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety","volume":"21","author":"Fabre","year":"1981","journal-title":"J Clin Pharmacol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1048","article-title":"Cannabis and anxiety: a critical review of the evidence","volume":"24","author":"Crippa","year":"2009","journal-title":"Hum Psychopharmacol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"15025","DOI":"10.1038\/s41598-017-14203-4","article-title":"Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors","volume":"7","author":"Bhattacharyya","year":"2017","journal-title":"Sci Rep"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61721-8","article-title":"Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials","volume":"370","author":"Christensen","year":"2007","journal-title":"Lancet"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2374","article-title":"Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report","volume":"29","author":"Bergamaschi","year":"2014","journal-title":"Hum Psychopharmacol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.2174\/1568026619666190708164841","article-title":"Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development","volume":"19","author":"Nguyen","year":"2019","journal-title":"Curr Top Med Chem"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00138","article-title":"Effects of Different Stressors Are Modulated by Different Neurobiological Systems: The Role of GABA-A Versus CB1 Receptor Gene Variants in Anxiety and Depression","volume":"13","author":"Gonda","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-018-0944-9","article-title":"Impact of FAAH genetic variation on fronto-amygdala function during emotional processing","volume":"269","author":"Gartner","year":"2019","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1600013113","article-title":"Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species","volume":"113","author":"Gee","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynstr.2019.100154","article-title":"FAAH genotype, CRFR1 genotype, and cortisol interact to predict anxiety in an aging, rural Hispanic population: A Project FRONTIER study","volume":"10","author":"Harris","year":"2019","journal-title":"Neurobiol Stress"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.12.021","article-title":"Interactions Between Anandamide and Corticotropin-Releasing Factor Signaling Modulate Human Amygdala Function and Risk for Anxiety Disorders: An Imaging Genetics Strategy for Modeling Molecular Interactions","volume":"80","author":"Demers","year":"2016","journal-title":"Biol Psychiatry"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2016.03.003","article-title":"Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma","volume":"26","author":"Lazary","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.07.083","article-title":"A functional variant of CB2 receptor gene interacts with childhood trauma and FAAH gene on anxious and depressive phenotypes","volume":"257","author":"Lazary","year":"2019","journal-title":"J Affect Disord"},{"key":"B177","volume-title":"Depression and other common mental disorders. Global health estimates.","year":"2017"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2007.05149.x","article-title":"BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice","volume":"105","author":"Aso","year":"2008","journal-title":"J Neurochem"},{"key":"B179","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.euroneuro.2010.06.007","article-title":"Genes differentially expressed in CB1 knockout mice: involvement in the depressive-like phenotype","volume":"21","author":"Aso","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"key":"B180","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.neuroscience.2011.09.031","article-title":"CB1 receptor-deficient mice as a model for depression","volume":"204","author":"Valverde","year":"2012","journal-title":"Neuroscience"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-200312000-00001","article-title":"Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice","volume":"14","author":"Shearman","year":"2003","journal-title":"Behav Pharmacol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.10.032","article-title":"Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents","volume":"57","author":"Griebel","year":"2005","journal-title":"Biol Psychiatry"},{"key":"B183","article-title":"Activation of endocannabinoid transmission induces antidepressant-like effects in rats","volume":"59","author":"Adamczyk","year":"2008","journal-title":"J Physiol Pharmacol"},{"key":"B184","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.bbr.2019.02.034","article-title":"Anxiolytic and antidepressant effects of ACPA and harmaline co-treatment","volume":"364","author":"Ebrahimi-Ghiri","year":"2019","journal-title":"Behav Brain Res"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2012.05.009","article-title":"Antidepressant-like effects of Delta(9)-tetrahydrocannabinol and rimonabant in the olfactory bulbectomised rat model of depression","volume":"102","author":"Elbatsh","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2017.01.018","article-title":"Activation of cannabinoid receptors elicits antidepressant-like effects in a mouse model of social isolation stress","volume":"130","author":"Haj-Mirzaian","year":"2017","journal-title":"Brain Res Bull"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2013.292","article-title":"Cannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression","volume":"39","author":"Segev","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2010.03.020","article-title":"Depression-like phenotype following chronic CB1 receptor antagonism","volume":"39","author":"Beyer","year":"2010","journal-title":"Neurobiol Dis"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0b013e3282ee7b44","article-title":"Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect","volume":"18","author":"McLaughlin","year":"2007","journal-title":"Behav Pharmacol"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0299-9","article-title":"Cannabinoid CB1 receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior","volume":"25","author":"Shen","year":"2019","journal-title":"Nat Med"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2008.05567.x","article-title":"Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment","volume":"106","author":"Hill","year":"2008","journal-title":"J Neurochem"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2009.05.013","article-title":"Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats","volume":"203","author":"Reich","year":"2009","journal-title":"Behav Brain Res"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2010.99","article-title":"Deficiency in endocannabinoid signaling in the nucleus accumbens induced by chronic unpredictable stress","volume":"35","author":"Wang","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.06.049","article-title":"Selectively Impaired Endocannabinoid-Dependent Long-Term Depression in the Lateral Habenula in an Animal Model of Depression","volume":"20","author":"Park","year":"2017","journal-title":"Cell Rep"},{"key":"B195","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neuint.2019.01.023","article-title":"Hemisphere-dependent endocannabinoid system activity in prefrontal cortex and hippocampus of the Flinders Sensitive Line rodent model of depression","volume":"125","author":"Kirkedal","year":"2019","journal-title":"Neurochem Int"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036743","article-title":"Dysfunction in fatty acid amide hydrolase is associated with depressive-like behavior in Wistar Kyoto rats","volume":"7","author":"Vinod","year":"2012","journal-title":"PloS One"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2007.09.003","article-title":"Enhancement of endocannabinoid signaling and the pharmacotherapy of depression","volume":"56","author":"Mangieri","year":"2007","journal-title":"Pharmacol Res"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.12.001","article-title":"Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress","volume":"62","author":"Bortolato","year":"2007","journal-title":"Biol Psychiatry"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2010.09.003","article-title":"Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats","volume":"60","author":"Realini","year":"2011","journal-title":"Neuropharmacology"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2017.01.054","article-title":"FAAH inhibition produces antidepressant-like efforts of mice to acute stress via synaptic long-term depression","volume":"324","author":"Wang","year":"2017","journal-title":"Behav Brain Res"},{"key":"B201","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/hipo.22344","article-title":"Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity","volume":"25","author":"Zhang","year":"2015","journal-title":"Hippocampus"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2019.10.010","article-title":"Dual pharmacological inhibitor of endocannabinoid degrading enzymes reduces depressive-like behavior in female rats","volume":"120","author":"Dong","year":"2020","journal-title":"J Psychiatr Res"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2016.149","article-title":"Brain cannabinoid receptor 2: expression, function and modulation","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol Sin"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001640","article-title":"Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects","volume":"3","author":"Onaivi","year":"2008","journal-title":"PloS One"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2009.02.018","article-title":"Depression-like behaviour in rats with mononeuropathy is reduced by the CB2-selective agonist GW405833","volume":"143","author":"Hu","year":"2009","journal-title":"Pain"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2016.01.006","article-title":"Role of hypothalamic cannabinoid receptors in post-stroke depression in rats","volume":"121","author":"Wang","year":"2016","journal-title":"Brain Res Bull"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2019.112439","article-title":"Antidepressant-like effects of beta-caryophyllene on restraint plus stress-induced depression","volume":"380","author":"Hwang","year":"2019","journal-title":"Behav Brain Res"},{"key":"B208","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s12640-014-9465-0","article-title":"Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures","volume":"26","author":"Smaga","year":"2014","journal-title":"Neurotox Res"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-008-0131-7","article-title":"Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents","volume":"115","author":"Hill","year":"2008","journal-title":"J Neural Transm (Vienna)"},{"key":"B210","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuro.2017.08.012","article-title":"Changes in the cannabinoids receptors in rats following treatment with antidepressants","volume":"63","author":"Smaga","year":"2017","journal-title":"Neurotoxicology"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2009.05898.x","article-title":"Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine","volume":"108","author":"Rodriguez-Gaztelumendi","year":"2009","journal-title":"J Neurochem"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1636-07.2007","article-title":"Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex","volume":"27","author":"Bambico","year":"2007","journal-title":"J Neurosci"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.12716","article-title":"Relationships between serotonergic and cannabinoid system in depressive-like behavior: a PET study with [11C.-DASB","volume":"130","author":"Burokas","year":"2014","journal-title":"J Neurochem"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2011.04.031","article-title":"Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice","volume":"223","author":"Umathe","year":"2011","journal-title":"Behav Brain Res"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301092","article-title":"Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis","volume":"31","author":"Hill","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108717","article-title":"Ketamine-induced antidepressant like effects in mice: A possible involvement of cannabinoid system","volume":"112","author":"Khakpai","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.12518","article-title":"Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice","volume":"43","author":"Ostadhadi","year":"2016","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B218","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbr.2015.01.051","article-title":"Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: mechanism of action and possible interactions with cholinergic system","volume":"284","author":"Kruk-Slomka","year":"2015","journal-title":"Behav Brain Res"},{"key":"B219","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jpsychires.2014.01.004","article-title":"Anti-depressive mechanism of repetitive transcranial magnetic stimulation in rat: the role of the endocannabinoid system","volume":"51","author":"Wang","year":"2014","journal-title":"J Psychiatr Res"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-018-2591-y","article-title":"Effects of rTMS on Hippocampal Endocannabinoids and Depressive-like Behaviors in Adolescent Rats","volume":"43","author":"Fang","year":"2018","journal-title":"Neurochem Res"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2019.172738","article-title":"Repetitive high-frequency transcranial magnetic stimulation reverses depressive-like behaviors and protein expression at hippocampal synapses in chronic unpredictable stress-treated rats by enhancing endocannabinoid signaling","volume":"184","author":"Xue","year":"2019","journal-title":"Pharmacol Biochem Behav"},{"key":"B222","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1471-4159.2007.04688.x","article-title":"Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity","volume":"103","author":"Hill","year":"2007","journal-title":"J Neurochem"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-007-0660-5","article-title":"Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression","volume":"114","author":"Koethe","year":"2007","journal-title":"J Neural Transm (Vienna)"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2012.03.021","article-title":"Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear","volume":"46","author":"Choi","year":"2012","journal-title":"J Psychiatr Res"},{"key":"B225","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/s41398-017-0029-y","article-title":"Schizophrenia and depression, two poles of endocannabinoid system deregulation","volume":"7","author":"Rodriguez-Munoz","year":"2017","journal-title":"Transl Psychiatry"},{"key":"B226","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1055\/s-2007-993211","article-title":"Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report","volume":"41","author":"Hill","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2009.03.013","article-title":"Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress","volume":"34","author":"Hill","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.02.026","article-title":"Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants","volume":"149","author":"Romero-Sanchiz","year":"2019","journal-title":"Neuropharmacology"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2011.09.017","article-title":"Intense exercise increases circulating endocannabinoid and BDNF levels in humans\u2013possible implications for reward and depression","volume":"37","author":"Heyman","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0000000000002006","article-title":"Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder","volume":"51","author":"Meyer","year":"2019","journal-title":"Med Sci Sports Exerc"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-017-0789-7","article-title":"Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study","volume":"267","author":"Kranaster","year":"2017","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2010.01.002","article-title":"Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression","volume":"61","author":"Monteleone","year":"2010","journal-title":"Pharmacol Res"},{"key":"B233","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.psychres.2011.11.021","article-title":"The CNR1 gene in depression and schizophrenia - is there an association with early improvement and response","volume":"196","author":"Schennach","year":"2012","journal-title":"Psychiatry Res"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2008.05.003","article-title":"Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression","volume":"18","author":"Domschke","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112454229","article-title":"Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes","volume":"26","author":"Mitjans","year":"2012","journal-title":"J Psychopharmacol"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2011.2273","article-title":"Cannabinoid receptor genotype moderation of the effects of childhood physical abuse on anhedonia and depression","volume":"69","author":"Agrawal","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2009.19","article-title":"CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms","volume":"34","author":"Juhasz","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500301","article-title":"Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1)","volume":"5","author":"Barrero","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12273","article-title":"A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients","volume":"24","author":"Icick","year":"2015","journal-title":"Am J Addict"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017403","article-title":"The association of endocannabinoid receptor genes (CNR1 and CNR2) polymorphisms with depression: A meta-analysis","volume":"98","author":"Kong","year":"2019","journal-title":"Med (Baltimore)"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1432.036","article-title":"Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression","volume":"1139","author":"Onaivi","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"B242","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","article-title":"Schizophrenia","volume":"388","author":"Owen","year":"2016","journal-title":"Lancet"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1808803","article-title":"Schizophrenia","volume":"381","author":"Marder","year":"2019","journal-title":"N Engl J Med"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2016.01.011","article-title":"Human Laboratory Studies on Cannabinoids and Psychosis","volume":"79","author":"Sherif","year":"2016","journal-title":"Biol Psychiatry"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2009.04.021","article-title":"Prepulse inhibition and genetic mouse models of schizophrenia","volume":"204","author":"Powell","year":"2009","journal-title":"Behav Brain Res"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1007\/7854_2010_61","article-title":"Prepulse inhibition of the startle reflex: a window on the brain in schizophrenia","volume":"4","author":"Braff","year":"2010","journal-title":"Curr Top Behav Neurosci"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1007\/BF02247436","article-title":", Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats","volume":"124","author":"Mansbach","year":"1996","journal-title":"Psychopharmacol (Berl)"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1240-x","article-title":"Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat","volume":"165","author":"Martin","year":"2003","journal-title":"Psychopharmacol (Berl)"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.12.005","article-title":"Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia","volume":"63","author":"Hajos","year":"2008","journal-title":"Biol Psychiatry"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00185","article-title":"NMDAR Hypofunction Animal Models of Schizophrenia","volume":"12","author":"Lee","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301344","article-title":"Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis","volume":"32","author":"Ballmaier","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"B252","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1017\/S1461145710000209","article-title":"Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine","volume":"14","author":"Guidali","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-010-2124-0","article-title":"AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents","volume":"215","author":"Black","year":"2011","journal-title":"Psychopharmacol (Berl)"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-016-9662-0","article-title":"The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801","volume":"30","author":"Kruk-Slomka","year":"2016","journal-title":"Neurotox Res"},{"key":"B255","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.neulet.2016.09.020","article-title":"Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia","volume":"633","author":"Szucs","year":"2016","journal-title":"Neurosci Lett"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2018.04.030","article-title":"Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia","volume":"201","author":"Gomes","year":"2018","journal-title":"Schizophr Res"},{"key":"B257","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.neuropharm.2019.05.015","article-title":"Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing\/cognitive deficit","volume":"155","author":"Almeida","year":"2019","journal-title":"Neuropharmacology"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2017.03.004","article-title":"Comparative analysis of MBD-seq and MeDIP-seq and estimation of gene expression changes in a rodent model of schizophrenia","volume":"109","author":"Neary","year":"2017","journal-title":"Genomics"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2015.169","article-title":"Schizophrenia-Like Phenotype Inherited by the F2 Generation of a Gestational Disruption Model of Schizophrenia","volume":"41","author":"Perez","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2018.11.006","article-title":"Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat","volume":"206","author":"Perez","year":"2019","journal-title":"Schizophr Res"},{"key":"B261","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1017\/S1461145708009371","article-title":"Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia","volume":"12","author":"Vigano","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2009.12.013","article-title":"A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy","volume":"61","author":"Eisenstein","year":"2010","journal-title":"Pharmacol Res"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2013.00106","article-title":"Neuregulin 1: a prime candidate for research into gene-environment interactions in schizophrenia? Insights from genetic rodent models","volume":"7","author":"Karl","year":"2013","journal-title":"Front Behav Neurosci"},{"key":"B264","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pnpbp.2016.08.006","article-title":"Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophrenia","volume":"72","author":"Clarke","year":"2017","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2009.09.024","article-title":"Brain cannabinoid CB2 receptor in schizophrenia","volume":"67","author":"Ishiguro","year":"2010","journal-title":"Biol Psychiatry"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.34","article-title":"Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice","volume":"36","author":"Ortega-Alvaro","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-014-3481-x","article-title":"CB2 receptor agonism reverses MK-801-induced disruptions of prepulse inhibition in mice","volume":"231","author":"Khella","year":"2014","journal-title":"Psychopharmacol (Berl)"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-017-9702-4","article-title":"The Impact of CB2 Receptor Ligands on the MK-801-Induced Hyperactivity in Mice","volume":"31","author":"Kruk-Slomka","year":"2017","journal-title":"Neurotox Res"},{"key":"B269","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0306-4522(00)00552-2","article-title":"Studies on [3H.CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use","volume":"103","author":"Dean","year":"2001","journal-title":"Neuroscience"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2012.07.021","article-title":"Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia","volume":"141","author":"Jenko","year":"2012","journal-title":"Schizophr Res"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2014.07.017","article-title":"Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia","volume":"159","author":"Volk","year":"2014","journal-title":"Schizophr Res"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.43","article-title":"Paranoid schizophrenia is characterized by increased CB1 receptor binding in the dorsolateral prefrontal cortex","volume":"36","author":"Dalton","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119857205","article-title":"Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia","volume":"33","author":"Muguruza","year":"2019","journal-title":"J Psychopharmacol"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2003.11.005","article-title":"Selective antagonist [3H.SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia","volume":"28","author":"Zavitsanou","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.1007\/s00221-006-0503-x","article-title":"Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia","volume":"172","author":"Newell","year":"2006","journal-title":"Exp Brain Res"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellbi.2007.01.007","article-title":"Enrichment of epidermal stem cells by rapid adherence and analysis of the reciprocal interaction of epidermal stem cells with neighboring cells using an organotypic system","volume":"31","author":"Dong","year":"2007","journal-title":"Cell Biol Int"},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.65.7.772","article-title":"Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia","volume":"65","author":"Eggan","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1608-2","article-title":"Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment","volume":"206","author":"Uriguen","year":"2009","journal-title":"Psychopharmacol (Berl)"},{"key":"B279","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2010.04.034","article-title":"Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C.OMAR","volume":"52","author":"Wong","year":"2010","journal-title":"Neuroimage"},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2013.04.052","article-title":"Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia","volume":"79","author":"Ceccarini","year":"2013","journal-title":"Neuroimage"},{"key":"B281","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.biopsych.2015.08.021","article-title":"Reduced Brain Cannabinoid Receptor Availability in Schizophrenia","volume":"79","author":"Ranganathan","year":"2016","journal-title":"Biol Psychiatry"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2016.04.015","article-title":"Positron Emission Tomography Studies on Cannabinoid Receptor Type 1 in Schizophrenia","volume":"79","author":"Mihov","year":"2016","journal-title":"Biol Psychiatry"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.1427","article-title":"In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis","volume":"76","author":"Borgan","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"B284","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.10038","article-title":"Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1","volume":"105","author":"Leroy","year":"2001","journal-title":"Am J Med Genet"},{"key":"B285","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001029","article-title":"CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia","volume":"7","author":"Ujike","year":"2002","journal-title":"Mol Psychiatry"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.107.036129","article-title":"Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use","volume":"191","author":"Zammit","year":"2007","journal-title":"Br J Psychiatry"},{"key":"B287","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neulet.2007.08.008","article-title":"No association of CNR1 gene variations with susceptibility to schizophrenia","volume":"426","author":"Seifert","year":"2007","journal-title":"Neurosci Lett"},{"key":"B288","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.euroneuro.2007.05.005","article-title":"The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia","volume":"18","author":"Hamdani","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"B289","doi-asserted-by":"publisher","DOI":"10.1097\/YPG.0000000000000047","article-title":"Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population","volume":"24","author":"Bae","year":"2014","journal-title":"Psychiatr Genet"},{"key":"B290","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2012.07.007","article-title":"Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-alpha gene (PPARA) and schizophrenia","volume":"23","author":"Costa","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"B291","doi-asserted-by":"publisher","DOI":"10.1097\/00041444-200010030-00008","article-title":"Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia","volume":"10","author":"Tsai","year":"2000","journal-title":"Psychiatr Genet"},{"key":"B292","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2015.05.005","article-title":"Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms","volume":"233","author":"Suarez-Pinilla","year":"2015","journal-title":"Psychiatry Res"},{"key":"B293","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.eurpsy.2019.07.004","article-title":"Association of CNR1 genotypes with changes in neurocognitive performance after eighteen-month treatment in patients with first-episode psychosis","volume":"61","author":"Rojnic Kuzman","year":"2019","journal-title":"Eur Psychiatry"},{"key":"B294","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318283925e","article-title":"CNR1 gene and risk of the metabolic syndrome in patients with schizophrenia","volume":"33","author":"Yu","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"B295","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1476-511X-2-5","article-title":"Endocannabinoid signalling in the blood of patients with schizophrenia","volume":"2","author":"De Marchi","year":"2003","journal-title":"Lipids Health Dis"},{"key":"B296","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2014.04.028","article-title":"Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia","volume":"156","author":"Ferretjans","year":"2014","journal-title":"Schizophr Res"},{"key":"B297","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jpsychires.2016.12.001","article-title":"Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: Evidence for defective immunomodulatory mechanisms","volume":"87","author":"de Campos-Carli","year":"2017","journal-title":"J Psychiatr Res"},{"key":"B298","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2016.08.055","article-title":"Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia","volume":"245","author":"Chase","year":"2016","journal-title":"Psychiatry Res"},{"key":"B299","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2017.01.022","article-title":"A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia","volume":"188","author":"D'Addario","year":"2017","journal-title":"Schizophr Res"},{"key":"B300","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199906030-00008","article-title":"Elevated endogenous cannabinoids in schizophrenia","volume":"10","author":"Leweke","year":"1999","journal-title":"Neuroreport"},{"key":"B301","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300558","article-title":"Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms","volume":"29","author":"Giuffrida","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"B302","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.schres.2007.04.025","article-title":"Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use","volume":"94","author":"Leweke","year":"2007","journal-title":"Schizophr Res"},{"key":"B303","doi-asserted-by":"publisher","DOI":"10.1080\/15622975.2018.1449966","article-title":"Familial abnormalities of endocannabinoid signaling in schizophrenia","volume":"20","author":"Koethe","year":"2019","journal-title":"World J Biol Psychiatry"},{"key":"B304","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107083816","article-title":"Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy","volume":"22","author":"Potvin","year":"2008","journal-title":"J Psychopharmacol"},{"key":"B305","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2012.00085","article-title":"Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the \u201cMirror Effect\u201d of Schizophrenia","volume":"3","author":"Desfosses","year":"2012","journal-title":"Front Psychiatry"},{"key":"B306","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2013.06.013","article-title":"Quantification of endocannabinoids in postmortem brain of schizophrenic subjects","volume":"148","author":"Muguruza","year":"2013","journal-title":"Schizophr Res"},{"key":"B307","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2004.11.050","article-title":"A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia","volume":"376","author":"Morita","year":"2005","journal-title":"Neurosci Lett"},{"key":"B308","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jpsychires.2016.01.002","article-title":"Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis","volume":"75","author":"Bioque","year":"2016","journal-title":"J Psychiatr Res"},{"key":"B309","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2013.02.038","article-title":"Endocannabinoid metabolism in the prefrontal cortex in schizophrenia","volume":"147","author":"Volk","year":"2013","journal-title":"Schizophr Res"},{"key":"B310","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2013.165","article-title":"Peripheral endocannabinoid system dysregulation in first-episode psychosis","volume":"38","author":"Bioque","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"B311","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-013-0062-0","article-title":"Association of single-nucleotide polymorphisms in the cannabinoid receptor 2 gene with schizophrenia in the Han Chinese population","volume":"51","author":"Tong","year":"2013","journal-title":"J Mol Neurosci"},{"key":"B312","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1017\/neu.2019.21","article-title":"Bipolar disorder and the endocannabinoid system","volume":"31","author":"Arjmand","year":"2019","journal-title":"Acta Neuropsychiatr"},{"key":"B313","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2011.01687.x","article-title":"Endocannabinoid system dysfunction in mood and related disorders","volume":"124","author":"Ashton","year":"2011","journal-title":"Acta Psychiatr Scand"},{"key":"B314","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5455\/dmm.20140428011918","article-title":"Rs6454674, Rs806368 and Rs1049353 CNR1 Gene Polymorphisms in Turkish Bipolar Disorder Patients: A Preliminary Study","volume":"2","author":"Alpak","year":"2014","journal-title":"Dis Mol Med"},{"key":"B315","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1259","article-title":"Association study between cannabinoid receptor gene (CNR1) and pathogenesis and psychotic symptoms of mood disorders","volume":"105","author":"Tsai","year":"2001","journal-title":"Am J Med Genet"},{"key":"B316","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2013.09.025","article-title":"No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample","volume":"210","author":"Pisanu","year":"2013","journal-title":"Psychiatry Res"},{"key":"B317","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2011.05.023","article-title":"Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor","volume":"134","author":"Minocci","year":"2011","journal-title":"J Affect Disord"},{"key":"B318","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.2508","article-title":"Association of Genetic Liability to Psychotic Experiences With Neuropsychotic Disorders and Traits","volume":"76","author":"Legge","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"B319","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.07.024","article-title":"The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings","volume":"111","author":"Berardi","year":"2016","journal-title":"Pharmacol Res"},{"key":"B320","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2470547019864096","article-title":"Endocannabinoid System Alterations in Posttraumatic Stress Disorder: A Review of Developmental and Accumulative Effects of Trauma","volume":"3","author":"Bassir Nia","year":"2019","journal-title":"Chronic Stress (Thousand Oaks)"},{"key":"B321","doi-asserted-by":"publisher","DOI":"10.1016\/j.nlm.2017.08.004","article-title":"The effects of cannabinoid receptors activation and glucocorticoid receptors deactivation in the amygdala and hippocampus on the consolidation of a traumatic event","volume":"144","author":"Shoshan","year":"2017","journal-title":"Neurobiol Learn Mem"},{"key":"B322","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2012.11.016","article-title":"Predator threat stress promotes long lasting anxiety-like behaviors and modulates synaptophysin and CB1 receptors expression in brain areas associated with PTSD symptoms","volume":"533","author":"Campos","year":"2013","journal-title":"Neurosci Lett"},{"key":"B323","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neulet.2011.05.013","article-title":"Cannabinoid receptor expression and phosphorylation are differentially regulated between male and female cerebellum and brain stem after repeated stress: implication for PTSD and drug abuse","volume":"502","author":"Xing","year":"2011","journal-title":"Neurosci Lett"},{"key":"B324","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-200509000-00016","article-title":"Differential response to acute and repeated stress in cannabinoid CB1 receptor knockout newborn and adult mice","volume":"16","author":"Fride","year":"2005","journal-title":"Behav Pharmacol"},{"key":"B325","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/npp.2014.225","article-title":"Interaction between the cholecystokinin and endogenous cannabinoid systems in cued fear expression and extinction retention","volume":"40","author":"Bowers","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"B326","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2014.132","article-title":"Cannabinoids prevent the effects of a footshock followed by situational reminders on emotional processing","volume":"39","author":"Korem","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"B327","doi-asserted-by":"publisher","DOI":"10.1002\/hipo.20711","article-title":"Cannabinoids modulate hippocampal memory and plasticity","volume":"20","author":"Abush","year":"2010","journal-title":"Hippocampus"},{"key":"B328","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.204","article-title":"Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress","volume":"37","author":"Ganon-Elazar","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"B329","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2013.01.014","article-title":"Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit","volume":"38","author":"Ganon-Elazar","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"B330","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2017.06.015","article-title":"Role of beta-catenin and endocannabinoids in the nucleus accumbens in extinction in rats exposed to shock and reminders","volume":"357","author":"Korem","year":"2017","journal-title":"Neuroscience"},{"key":"B331","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2014.05.007","article-title":"Peripheral and intra-dorsolateral striatum injections of the cannabinoid receptor agonist WIN 55,212-2 impair consolidation of stimulus-response memory","volume":"274","author":"Goodman","year":"2014","journal-title":"Neuroscience"},{"key":"B332","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113499207","article-title":"Cannabinoid modulation of chronic mild stress-induced selective enhancement of trace fear conditioning in adolescent rats","volume":"27","author":"Reich","year":"2013","journal-title":"J Psychopharmacol"},{"key":"B333","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300655","article-title":"Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear","volume":"30","author":"Chhatwal","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"B334","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-018-5020-7","article-title":"Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety","volume":"235","author":"Danandeh","year":"2018","journal-title":"Psychopharmacol (Berl)"},{"key":"B335","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2018.02.004","article-title":"Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD","volume":"28","author":"Fidelman","year":"2018","journal-title":"Eur Neuropsychopharmacol"},{"key":"B336","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107804","article-title":"and cannabinoids interaction in the amygdala after exposure to shock and reminders model of PTSD","volume":"162","author":"Maymon","year":"2020","journal-title":"Neuropharmacology"},{"key":"B337","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-018-0135-4","article-title":"Role of endocannabinoids in the hippocampus and amygdala in emotional memory and plasticity","volume":"43","author":"Segev","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"B338","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301224","article-title":"Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task","volume":"32","author":"Varvel","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"B339","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.15l10084","article-title":"The rs1049353 polymorphism in the CNR1 gene interacts with childhood abuse to predict posttraumatic threat symptoms","volume":"76","author":"Mota","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"B340","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.30693","article-title":"Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder","author":"Lu","year":"2008","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"B341","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2013.08.004","article-title":"Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks","volume":"38","author":"Hill","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"B342","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2013.61","article-title":"Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study","volume":"18","author":"Neumeister","year":"2013","journal-title":"Mol Psychiatry"},{"key":"B343","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.psyneuen.2016.02.010","article-title":"Endocannabinoid concentrations in hair are associated with PTSD symptom severity","volume":"67","author":"Wilker","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"B344","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.biopsych.2008.10.047","article-title":"Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function","volume":"66","author":"Hariri","year":"2009","journal-title":"Biol Psychiatry"},{"key":"B345","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2012.72","article-title":"Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity","volume":"18","author":"Gunduz-Cinar","year":"2013","journal-title":"Mol Psychiatry"},{"key":"B346","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.1038\/ncomms7395","article-title":"FAAH genetic variation enhances fronto-amygdala function in mouse and human","volume":"6","author":"Dincheva","year":"2015","journal-title":"Nat Commun"},{"key":"B347","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.neuropharm.2012.06.063","article-title":"Cannabinoid facilitation of fear extinction memory recall in humans","volume":"64","author":"Rabinak","year":"2013","journal-title":"Neuropharmacology"},{"key":"B348","doi-asserted-by":"publisher","DOI":"10.1016\/j.nlm.2013.09.009","article-title":"Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans","volume":"113","author":"Rabinak","year":"2014","journal-title":"Neurobiol Learn Mem"},{"key":"B349","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-014-0212-3","article-title":"Preliminary, open-label, pilot study of add-on oral Delta9-tetrahydrocannabinol in chronic post-traumatic stress disorder","volume":"34","author":"Roitman","year":"2014","journal-title":"Clin Drug Invest"},{"key":"B350","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2014.11.002","article-title":"The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study","volume":"51","author":"Jetly","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"B351","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000180","article-title":"Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation","volume":"34","author":"Cameron","year":"2014","journal-title":"J Clin Psychopharmacol"},{"key":"B352","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.14348","article-title":"Caffeine and cannabinoid receptors modulate impulsive behavior in an animal model of attentional deficit and hyperactivity disorder","volume":"49","author":"Leffa","year":"2019","journal-title":"Eur J Neurosci"},{"key":"B353","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13776","article-title":"Heterologous regulation of the cannabinoid type 1 receptor by angiotensin II in astrocytes of spontaneously hypertensive rats","volume":"139","author":"Haspula","year":"2016","journal-title":"J Neurochem"},{"key":"B354","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2014.313","article-title":"Dissociable deficits of executive function caused by gestational adversity are linked to specific transcriptional changes in the prefrontal cortex","volume":"40","author":"Grissom","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"B355","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-789X.2010.00850.x","article-title":"Pre-pregnancy and pregnancy obesity and neurodevelopmental outcomes in offspring: a systematic review","volume":"12","author":"Van Lieshout","year":"2011","journal-title":"Obes Rev"},{"key":"B356","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2012.03.002","article-title":"Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation","volume":"60","author":"Kleijn","year":"2012","journal-title":"Neurochem Int"},{"key":"B357","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-014-1266-3","article-title":"Role of CNR1 polymorphisms in moderating the effects of psychosocial adversity on impulsivity in adolescents","volume":"122","author":"Buchmann","year":"2015","journal-title":"J Neural Transm (Vienna)"},{"key":"B358","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001278","article-title":"Association between cannabinoid receptor gene (CNR1) and childhood attention deficit\/hyperactivity disorder in Spanish male alcoholic patients","volume":"8","author":"Ponce","year":"2003","journal-title":"Mol Psychiatry"},{"key":"B359","doi-asserted-by":"publisher","DOI":"10.1177\/0269881111408458","article-title":"The role of the endocannabinoid system in the neuroendocrine regulation of energy balance","volume":"26","author":"Bermudez-Silva","year":"2012","journal-title":"J Psychopharmacol"},{"key":"B360","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2011.05.002","article-title":"Energy balance regulation by endocannabinoids at central and peripheral levels","volume":"17","author":"Quarta","year":"2011","journal-title":"Trends Mol Med"},{"key":"B361","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2012.12.004","article-title":"Tolerance to hypophagia induced by prolonged treatment with a CB1 antagonist is related to the reversion of anorexigenic neuropeptide gene expression in the hypothalamus","volume":"182","author":"Rorato","year":"2013","journal-title":"Regul Pept"},{"key":"B362","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2009.06750.x","article-title":"Involvement of hypothalamic peptides in the anorectic action of the CB receptor antagonist rimonabant (SR 141716)","volume":"29","author":"Verty","year":"2009","journal-title":"Eur J Neurosci"},{"key":"B363","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv011","article-title":"Lack of Hypophagia in CB1 Null Mice is Associated to Decreased Hypothalamic POMC and CART Expression","volume":"18","author":"Lage","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"B364","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pbb.2017.10.013","article-title":"A behavioral and pharmacological characterization of palatable diet alternation in mice","volume":"163","author":"Moore","year":"2017","journal-title":"Pharmacol Biochem Behav"},{"key":"B365","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2008.00107.x","article-title":"Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice","volume":"156","author":"Riedel","year":"2009","journal-title":"Br J Pharmacol"},{"key":"B366","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/sj.bjp.0706157","article-title":"CB1 cannabinoid receptor-mediated modulation of food intake in mice","volume":"145","author":"Wiley","year":"2005","journal-title":"Br J Pharmacol"},{"key":"B367","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(76)90202-1","article-title":"Comparative effects of various naturally occurring cannabinoids on food, sucrose and water consumption by rats","volume":"4","author":"Sofia","year":"1976","journal-title":"Pharmacol Biochem Behav"},{"key":"B368","article-title":"The effects of leptin in combination with a cannabinoid receptor 1 antagonist, AM 251, or cannabidiol on food intake and body weight in rats fed a high-fat or a free-choice high sugar diet","volume":"65","author":"Wierucka-Rybak","year":"2014","journal-title":"J Physiol Pharmacol"},{"key":"B369","doi-asserted-by":"publisher","DOI":"10.1002\/eat.23157","article-title":"Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa","volume":"52","author":"Collu","year":"2019","journal-title":"Int J Eat Disord"},{"key":"B370","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300695","article-title":"Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa","volume":"30","author":"Monteleone","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"B371","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2011.05.010","article-title":"Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa","volume":"70","author":"Gerard","year":"2011","journal-title":"Biol Psychiatry"},{"key":"B372","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2012.03.025","article-title":"Lower levels of cannabinoid 1 receptor mRNA in female eating disorder patients: association with wrist cutting as impulsive self-injurious behavior","volume":"37","author":"Schroeder","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"B373","doi-asserted-by":"publisher","first-page":"16023","DOI":"10.1038\/npjsba.2016.23","article-title":"Molecular mechanisms involved in the side effects of fatty acid amide hydrolase inhibitors: a structural phenomics approach to proteome-wide cellular off-target deconvolution and disease association","volume":"2","author":"Dider","year":"2016","journal-title":"NPJ Syst Biol Appl"},{"key":"B374","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.lfs.2018.04.054","article-title":"Enhanced endocannabinoid tone as a potential target of pharmacotherapy","volume":"204","author":"Toczek","year":"2018","journal-title":"Life Sci"},{"key":"B375","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2011.00064","article-title":"Sexually dimorphic effects of cannabinoid compounds on emotion and cognition","volume":"5","author":"Rubino","year":"2011","journal-title":"Front Behav Neurosci"},{"key":"B376","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41386-018-0153-2","article-title":"Sex differences in psychiatric disorders: what we can learn from sex chromosome aneuploidies","volume":"44","author":"Green","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"B377","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/npp.2017.140","article-title":"Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective","volume":"43","author":"Cooper","year":"2018","journal-title":"Neuropsychopharmacology"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00315\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T09:35:06Z","timestamp":1589189706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00315\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,27]]},"references-count":377,"alternative-id":["10.3389\/fpsyt.2020.00315"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2020.00315","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,27]]},"article-number":"315"}}